Trial Outcomes & Findings for VOICE: Values and Options in Cancer Care (NCT NCT01485627)
NCT ID: NCT01485627
Last Updated: 2019-01-10
Results Overview
We audio recorded the first physician visit after the coaching session (for intervention) or after study entry (control).The primary outcome was a composite of 4 pre-specified communication measures: 1. engaging patients in consultations, responding to patients' emotions, informing patients about prognosis and treatment choices and balanced framing of decisions. Coding of the 4 measures was performed by teams of trained university students who were audited continuously and blinded to study hypotheses and group assignment. We transformed each of the 4 component scores to z scores based on the pre-randomization phase sample means (SDs): z = (Raw Score - Pre-randomization Phase Mean)/Pre-randomization Phase SD. The 4-component z-scores were averaged to form the primary outcome. A higher Z score indicates better communication. The maximum possible Z-score ranged from -0.69 to 20.08.
COMPLETED
NA
485 participants
3 years
2019-01-10
Participant Flow
54 physicians were assessed for eligibility. Of these 2 were ineligible and 9 refused participation. 43 physicians were included in the pre-randomized phase and of these 2 withdrew and 3 did not enroll enough patients. Patients from 38 physicians were included for the cluster randomized clinical trial phase of the study.
233 caregivers and 316 patients were consented. 204 caregivers were allocated and 127 of them were bereaved. 24 caregivers failed screening and 5 withdrew during screening. 26 patients failed screening and 9 withdrew during screening.
Unit of analysis: physicians
Participant milestones
| Measure |
Intervention: Communication
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
|
Control: Usual Care
Patients will receive usual care
|
|---|---|---|
|
Overall Study
STARTED
|
244 19
|
241 19
|
|
Overall Study
Allocated Caregivers: Total
|
105 19
|
99 19
|
|
Overall Study
Bereaved Caregivers: Total
|
63 19
|
64 19
|
|
Overall Study
Bereaved Caregivers: 1 Month
|
51 19
|
51 19
|
|
Overall Study
Bereaved Caregivers: 2 Month Completed
|
49 19
|
52 19
|
|
Overall Study
Bereaved Caregivers: 7 Month Completed
|
48 19
|
49 19
|
|
Overall Study
COMPLETED
|
178 19
|
184 19
|
|
Overall Study
NOT COMPLETED
|
66 0
|
57 0
|
Reasons for withdrawal
| Measure |
Intervention: Communication
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
|
Control: Usual Care
Patients will receive usual care
|
|---|---|---|
|
Overall Study
Patient withdrew
|
6
|
5
|
|
Overall Study
Patient died
|
3
|
1
|
|
Overall Study
Patient lost to followup
|
0
|
1
|
|
Overall Study
Caregiver withdrew
|
3
|
3
|
|
Overall Study
Caregiver lost to follow up
|
11
|
12
|
|
Overall Study
Caregiver died
|
1
|
0
|
|
Overall Study
caregiver was not bereaved
|
42
|
35
|
Baseline Characteristics
Region of enrollment for caregivers only
Baseline characteristics by cohort
| Measure |
Intervention: Communication Training
n=180 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
|
Control: Usual Care
n=188 Participants
Patients will receive usual care
|
Total
n=368 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Region of Enrollment
United States
|
50 participants
n=50 Participants • Region of enrollment for caregivers only
|
53 participants
n=53 Participants • Region of enrollment for caregivers only
|
265 participants
n=265 Participants • Region of Enrollment for patients only
|
|
Age, Categorical
<=18 years
|
0 Participants
n=50 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
|
0 Participants
n=53 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
|
0 Participants
n=103 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
|
|
Age, Categorical
Between 18 and 65 years
|
21 Participants
n=50 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
|
27 Participants
n=53 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
|
48 Participants
n=103 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
|
|
Age, Categorical
>=65 years
|
29 Participants
n=50 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
|
26 Participants
n=53 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
|
55 Participants
n=103 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
|
|
Age, Continuous
|
64.2 years
STANDARD_DEVIATION 11.7 • n=130 Participants • Age continuous was collected for the patients.
|
64.5 years
STANDARD_DEVIATION 11 • n=135 Participants • Age continuous was collected for the patients.
|
64.4 years
STANDARD_DEVIATION 11.4 • n=265 Participants • Age continuous was collected for the patients.
|
|
Sex: Female, Male
patients · Female
|
76 Participants
n=130 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
70 Participants
n=135 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
146 Participants
n=265 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
|
Sex: Female, Male
patients · Male
|
54 Participants
n=130 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
65 Participants
n=135 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
119 Participants
n=265 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
|
Sex: Female, Male
Caregivers · Female
|
25 Participants
n=50 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
29 Participants
n=53 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
54 Participants
n=103 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
|
Sex: Female, Male
Caregivers · Male
|
25 Participants
n=50 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
24 Participants
n=53 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
49 Participants
n=103 Participants • The overall number of participants is the total of caregivers and patients for each arm.
|
|
Race (NIH/OMB)
patients · American Indian or Alaska Native
|
0 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
patients · Asian
|
0 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
patients · Native Hawaiian or Other Pacific Islander
|
0 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
patients · Black or African American
|
0 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
patients · White
|
116 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
|
119 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
|
235 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
patients · More than one race
|
0 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
patients · Unknown or Not Reported
|
14 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
|
16 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
|
30 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
Caregivers · American Indian or Alaska Native
|
0 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
Caregivers · Asian
|
0 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
Caregivers · Native Hawaiian or Other Pacific Islander
|
0 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
Caregivers · Black or African American
|
0 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
Caregivers · White
|
44 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
|
46 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
|
90 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
Caregivers · More than one race
|
0 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
|
0 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
|
|
Race (NIH/OMB)
Caregivers · Unknown or Not Reported
|
6 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
|
7 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
|
13 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
|
PRIMARY outcome
Timeframe: 3 yearsPopulation: This outcome measure was assessed in patients only.
We audio recorded the first physician visit after the coaching session (for intervention) or after study entry (control).The primary outcome was a composite of 4 pre-specified communication measures: 1. engaging patients in consultations, responding to patients' emotions, informing patients about prognosis and treatment choices and balanced framing of decisions. Coding of the 4 measures was performed by teams of trained university students who were audited continuously and blinded to study hypotheses and group assignment. We transformed each of the 4 component scores to z scores based on the pre-randomization phase sample means (SDs): z = (Raw Score - Pre-randomization Phase Mean)/Pre-randomization Phase SD. The 4-component z-scores were averaged to form the primary outcome. A higher Z score indicates better communication. The maximum possible Z-score ranged from -0.69 to 20.08.
Outcome measures
| Measure |
Intervention
n=130 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
|
Control
n=135 Participants
Patients will receive usual care
|
|---|---|---|
|
Mean Patient-centered Communication in Advanced Cancer Score
|
0.16 standardized score on a scale
Standard Deviation 0.81
|
-0.01 standardized score on a scale
Standard Deviation 0.66
|
SECONDARY outcome
Timeframe: 7 monthsPopulation: This instrument was used with caregivers only.
The prolonged grief (PG-13) instrument was used to measure prolonged grief. The tool is a sum of ten items that measure separation distress, duration of grief, cognitive, emotional, and behavioral symptoms and impairment criterion. The range of the score is 10-50 with higher scores indicating more severe symptoms.
Outcome measures
| Measure |
Intervention
n=48 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
|
Control
n=49 Participants
Patients will receive usual care
|
|---|---|---|
|
Caregiver Mean Prolonged Grief Symptoms as Measured by PG-13
|
19.3 units on a scale
Standard Deviation 5.9
|
20.6 units on a scale
Standard Deviation 6.8
|
SECONDARY outcome
Timeframe: 3 yearsPopulation: This outcome measure was assessed in patients only.
Patients and physicians were asked what the likelihood of survival in 2 years would be for the patient. They chose from 0, 10, 25, 50, 75, 90, 100% chance of survival in two years. A value of 0-6 was assigned to each pair of data. 0 indicating no difference in the reported value between patient and physician and 6 indicating the largest difference. For example if the physician said 100% and the patient said 0% the score was 6. The mean scores were reported by arm.
Outcome measures
| Measure |
Intervention
n=130 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
|
Control
n=135 Participants
Patients will receive usual care
|
|---|---|---|
|
Aim 1b&c Mean Difference in Reported Expectation of Survival in 2 Years Between Patients and Physicians
|
2.2 units on a scale
Standard Deviation 1.5
|
2.5 units on a scale
Standard Deviation 1.6
|
SECONDARY outcome
Timeframe: 3 yearsPopulation: This outcome measure was assessed in patients only.
Original McGill quality of life and the FACT-G assessment tools were used. For the McGill tool scores range from 1 to 10 with higher scores indicating better outcome. For FACT-G scores range from 0 to 4. Higher score means a better outcome. Different parts of the McGill and FACT-G tools were used to create 5 standardized z scores: McGill QOL Scale single item, McGill Psychological Well-Being sub-scale, McGill Existential Well-Being sub-scale, FACT-G Physical Functioning sub-scale and FACT-G Social Functioning sub-scale. Sum of the five standardized z-scores is the Aggregate QOL score. A higher Z score indicates better outcomes. The maximum possible Z-score ranged from -3.54 to 1.24.
Outcome measures
| Measure |
Intervention
n=130 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
|
Control
n=135 Participants
Patients will receive usual care
|
|---|---|---|
|
Aim 2 Patient Well-being
|
-0.01 standardized score on a scale
Standard Deviation 0.73
|
-0.07 standardized score on a scale
Standard Deviation 0.80
|
SECONDARY outcome
Timeframe: 7 monthsPopulation: Sf-12 was given to the caregivers only.
SF-12 scores are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.
Outcome measures
| Measure |
Intervention
n=48 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
|
Control
n=49 Participants
Patients will receive usual care
|
|---|---|---|
|
Caregiver Mean Overall Mental Health as Measured by the SF-12 Assessment
|
48.9 units on a scale
Standard Deviation 9.6
|
47.9 units on a scale
Standard Deviation 11.5
|
SECONDARY outcome
Timeframe: 3 yearsPopulation: Health care utilization was assessed in patients only.
Patient charts were audited for 3 outcomes : 1) chemotherapy use, 2) aggressive treatments and 3) emergency department or hospital utilization. The total scores ranged from 0-6 with higher scores indicated worse outcomes. The sums of the means for the 3 outcomes were added to provide the total score.
Outcome measures
| Measure |
Intervention
n=130 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
|
Control
n=135 Participants
Patients will receive usual care
|
|---|---|---|
|
Health Care Utilization- Mean Index Score of Aggressive Care at the End of Life
|
0.76 units on a scale
Standard Deviation 1.1
|
0.58 units on a scale
Standard Deviation 0.9
|
Adverse Events
Intervention-patients
Control-patients
Intervention- Caregivers
Intervention-caregivers
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Ronald Epstein MD
UNIVERSITY OF ROCHESTER DEPARTMENT OF FAMILY MEDICINE
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place